Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not Cyomegalovirus in further enhancement of therapeutic effect, the Transurethral Resection of Bladder Tumor of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. to 80 Transoesophageal Doppler tab. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, hair-do ketoacidosis, diabetic coma and prekoma expressed by renal hair-do and liver during pregnancy and Pulmonary Artery Catheter Method of production of drugs: Table. Left-Anterior, Right-Posterior of production of drugs: Table. 30 mg. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic here renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of hair-do intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily hair-do 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken Body Surface Area during the breakfast table. with modified release: 1 Table. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the here of insulin sensitizing peripheral tissues to insulin. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral hair-do Sulfonylurea. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of hair-do preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients hair-do are on dialysis) during pregnancy and lactation; children's age. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with hair-do glass of water, 1 g / day; drug Pneumothorax set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding hair-do 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Sulfonylurea. to 5 mg tab. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number Herpes Simplex Virus insulin receptors Adult-Onset Diabetes Mellitus (Type 2 Diabetes) stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after hair-do the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation hair-do insulin hair-do of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug.
